AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)

A total of 24 accepted abstracts, including six oral and digital oral presentations, reinforce AbbVie's commitment to research that helps advance standards of...

Related Keywords

Ohio ,United States ,Italy ,Milan ,Lombardia ,Denmark ,Copenhagen ,Køavn ,Silvio Danese ,Ann Gastroenterol ,Gastroenterol Hepatol ,Abbvie Ltd ,Peuropean Society Of Gastrointestinal Endoscopy ,European Society Of Neurogastroenterology ,Boehringer Ingelheim ,Exchange Commission ,University Vita ,Allergan ,Abbvie Inc ,Colitis Organisation ,Crohn Colitis Foundation Of America ,European Crohn ,Sofie Berg ,European Society ,Gastrointestinal Endoscopy ,Plenary Hall ,San Raffaele ,University Vita Salute San Raffaele ,Important Safety Information ,Medication Guide ,Consumer Brief Summary ,Mississippi River ,Full Prescribing Information ,Allergic Reactions ,Pregnancy Registry ,Allergan Aesthetics ,Private Securities Litigation Reform Act ,Quarterly Reports ,Inflammatory Bowel ,Colitis Foundation ,Rev Gastroenterol ,North Chicago ,Placebo Controlled Study ,Endoscopic Remission ,Subjects With Moderately ,Severely Active Crohn ,Disease Who Have Inadequately Responded ,Are Intolerant ,Participants With Giant Cell Arteritis ,Study Comparing Upadacitinib ,Participants With Psoriatic Arthritis Who Have ,Inadequate Response ,Compare Safety ,Adult Participants With Moderate ,Severe Atopic Dermatitis ,Subjects With Takayasu Arteritis ,Evaluate Efficacy ,Adult Participants With Axial Spondyloarthritis ,Placebo Controlled Induction Study ,Participants With Moderately ,Severely Active Ulcerative ,Abbvie ,